Head and Neck Cancers
David G. Pfister(Memorial Sloan Kettering Cancer Center), Frank Worden(University of Michigan), Giuseppe Sanguineti(National Cancer Institute), Frank Dunphy, Ellie Maghami(City Of Hope National Medical Center), Barbara Burtness(Yale University), Jatin P. Shah(Memorial Sloan Kettering Cancer Center), Ying J. Hitchcock(University of Utah), Sharon Spencer(University of Colorado Cancer Center), Anthony J. Cmelak(Breast Cancer Research Foundation), David M. Brizel(Duke University), Randal S. Weber(The University of Texas MD Anderson Cancer Center), Andy Trotti, John A. Ridge(Fox Chase Cancer Center), Bruce H. Haughey(AdventHealth Celebration), A. Dimitrios Colevas(Cancer Institute (WIA)), Renato Martins(Seattle Cancer Care Alliance), Wesley L. Hicks, Maura L. Gillison(The University of Texas MD Anderson Cancer Center), Robert I. Haddad(Georgetown University), Gregory T. Wolf(University of Michigan), William M. Lydiatt(Creighton University), David E. Schuller(Ohio State University Hospital), Jill Gilbert(Cancer Clinic), Merrill S. Kies(The University of Texas MD Anderson Cancer Center), Sandeep Samant, Kie-Kian Ang(Radiation Oncology Associates), Thomas V. McCaffrey, Bharat B. Mittal(Northwestern University), Harlan A. Pinto(Cancer Institute (WIA)), David W. Eisele(Sidney Kimmel Comprehensive Cancer Center)
Cited by 415
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
|Journal of Clinical Oncology|2011|3.6k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k